Brainsway logo
BWAYBrainsway
Trade BWAY now
Brainsway primary media

About Brainsway

Brainsway (TLV:BWAY), (NASDAQ:BWAY) specializes in the development and marketing of advanced neurostimulation treatments for mental health disorders. The company's main focus is on its patented Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a non-invasive treatment designed to target areas of the brain associated with mood and behavior disorders. Brainsway aims to improve the well-being of patients suffering from a variety of mental health conditions, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction, among others. Through continuous research and development, Brainsway strives to expand the applications of Deep TMS technology to address a wider range of neurological and psychiatric disorders, working towards the objective of offering effective, accessible, and safe treatment alternatives for patients worldwide.

What is BWAY known for?

Snapshot

Public US
Ownership
2003
Year founded
134
Employees
Jerusalem, Israel
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
State of Israel

Produtos e/ou serviços de Brainsway

  • Deep TMS Therapy - A non-invasive treatment for depression and OCD using magnetic fields to stimulate brain regions.
  • Smoking Cessation - TMS technology aimed at helping individuals quit smoking.
  • Obsessive-Compulsive Disorder Treatment - Offering a specialized TMS coil designed for patients with OCD.
  • Alzheimer's Disease Management - Developing TMS solutions to alleviate symptoms of Alzheimer's disease.
  • Anxiety Disorder Treatment - Utilizing TMS to reduce symptoms of various anxiety disorders.
  • Bipolar Depression Treatment - Tailored TMS protocols to address the depressive phase in bipolar disorder patients.

equipe executiva do Brainsway

  • Mr. Hadar LevyChief Executive Officer
  • Dr. David Zacut M.D.Co-Founder & Vice-Chairman
  • Mr. Avner HagaiFounder & Director
  • Prof. Abraham Zangen Ph.D.Co-Founder, Member of Scientific Advisory Board & Director
  • Mr. Ido MaromChief Financial Officer
  • Dr. Colleen Hanlon Ph.D.Vice President of Medical Affairs
  • Mr. Michael CohenVice President of US Sales
  • Dr. Yiftach Roth Ph.D.Founder & Chief Scientific Officer
  • Mr. Dor HagaiVice President of Operations
  • Mr. Gilead Moiseyev Ph.D.Chief Technology Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.